| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
15,030,000 |
| Market
Cap: |
24.05(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.45 - $2.49 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Rafael Holdings holds interests in clinical and early stage pharmaceutical companies and commercial real estate assets. Co. has an investment in Rafael Pharmaceuticals, Inc., a late-stage cancer metabolism-based therapeutics company. In addition, Co. has established the Barer Institute as an early-stage small molecule research institute that develops therapeutic compounds, including compounds to regulate cancer metabolism with application in other indications beyond cancer. Co. also holds a majority equity interest in LipoMedix Pharmaceuticals Ltd., a clinical stage oncological pharmaceutical company based in Israel. Co.'s commercial real estate holdings include the building in Newark, NJ.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
3,225,806 |
| Total Buy Value |
$0 |
$0 |
$0 |
$5,999,999 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
225,122 |
| Total Sell Value |
$0 |
$0 |
$0 |
$423,290 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
6 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mccamish Mark Anthony |
Director |
– • – |
2023-01-05 |
4 |
A |
$1.84 |
$50,000 |
D/D |
27,174 |
32,586 |
|
- |
|
| Jonas Howard S |
Executive Chairman |
• • – |
2022-08-09 |
4 |
AS |
$1.84 |
$118,948 |
I/I |
(64,674) |
3,225,806 |
|
-3% |
|
| I9 Plus, Llc |
10% Owner |
– – • |
2022-08-09 |
4 |
AS |
$1.84 |
$118,948 |
D/D |
(64,674) |
3,225,806 |
|
-3% |
|
| Jonas Howard S |
Executive Chairman |
• • – |
2022-08-08 |
4 |
AS |
$1.94 |
$28,678 |
I/I |
(14,787) |
3,290,480 |
|
-10% |
|
| I9 Plus, Llc |
10% Owner |
– – • |
2022-08-08 |
4 |
AS |
$1.94 |
$28,678 |
D/D |
(14,787) |
3,290,480 |
|
-10% |
|
| Jonas Howard S |
Executive Chairman |
• • – |
2022-08-05 |
4 |
AS |
$1.93 |
$64,019 |
I/I |
(33,100) |
3,305,267 |
|
-9% |
|
| I9 Plus, Llc |
10% Owner |
– – • |
2022-08-05 |
4 |
AS |
$1.93 |
$64,019 |
D/D |
(33,100) |
3,305,267 |
|
-9% |
|
| I9 Plus, Llc |
10% Owner |
– – • |
2022-07-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,338,367 |
|
-4% |
|
| Jonas Howard S |
Executive Chairman |
• • – |
2022-07-06 |
4 |
B |
$1.86 |
$5,999,999 |
I/I |
3,225,806 |
3,338,367 |
2.66 |
-4% |
|
| Jonas Howard S |
Chairman of the Board |
• • – |
2022-06-14 |
4 |
A |
$1.88 |
$850,004 |
D/D |
452,130 |
452,130 |
|
- |
|
| Mallik Ameet |
Director |
– • – |
2022-02-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(908,497) |
0 |
|
- |
|
| Conkling William |
Chief Executive Officer |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
623,732 |
623,732 |
|
- |
|
| Fabbio Patrick |
CFO & President |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
363,103 |
363,103 |
|
- |
|
| Greenberg Stephen M |
Director |
– • – |
2022-01-19 |
4 |
A |
$5.39 |
$40,490 |
D/D |
7,512 |
20,121 |
|
- |
|
| Mccamish Mark Anthony |
Director |
– • – |
2022-01-05 |
4 |
A |
$5.39 |
$29,171 |
D/D |
5,412 |
5,412 |
|
- |
|
| Klinger Shannon Thyme |
Director |
– • – |
2022-01-05 |
4 |
A |
$5.39 |
$29,171 |
D/D |
5,412 |
5,412 |
|
- |
|
| Pasche Boris C |
Director |
– • – |
2022-01-05 |
4 |
A |
$5.39 |
$40,490 |
D/D |
7,512 |
20,121 |
|
- |
|
| Polinsky David |
Former Chief Financial Officer |
• – – |
2021-09-23 |
4 |
D |
$35.77 |
$20,425 |
D/D |
(571) |
17,429 |
|
- |
|
| Jonas Howard S |
Chief Executive Officer |
• • • |
2021-08-24 |
4 |
B |
$44.92 |
$5,056,240 |
I/I |
112,561 |
112,561 |
2.64 |
-87% |
|
| Mallik Ameet |
CHIEF EXECUTIVE OFFICER |
• – – |
2021-05-27 |
4 |
A |
$44.70 |
$40,609,816 |
D/D |
908,497 |
908,497 |
|
- |
|
| Weiss Michael J |
Director |
– • – |
2021-01-19 |
4 |
A |
$5.39 |
$40,490 |
D/D |
7,512 |
20,121 |
|
- |
|
| Jonas Rachel |
Director |
– • – |
2021-01-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
778 |
|
79% |
|
| Greenberg Stephen M |
Director |
– • – |
2021-01-05 |
4 |
A |
$22.72 |
$95,492 |
D/D |
4,203 |
12,609 |
|
- |
|
| Weiss Michael J |
Director |
– • – |
2021-01-05 |
4 |
A |
$22.72 |
$95,492 |
D/D |
4,203 |
12,609 |
|
- |
|
| Ash Menachem |
President |
• – – |
2021-01-05 |
4 |
D |
$22.72 |
$122,802 |
D/D |
(5,405) |
126,440 |
|
- |
|
79 Records found
|
|
Page 2 of 4 |
|
|
0.01 (0.63%) 
